KRAS and TP53 mutations in inflammatory bowel disease-associated colorectal cancer: a meta-analysis

Although KRAS and TP53 mutations are common in both inflammatory bowel disease-associated colorectal cancer (IBD-CRC) and sporadic colorectal cancer (S-CRC), molecular events leading to carcinogenesis may be different. Previous studies comparing the frequency of KRAS and TP53 mutations in IBD-CRC an...

Descripción completa

Detalles Bibliográficos
Autores principales: Du, Lijun, Kim, John J., Shen, Jinhua, Chen, Binrui, Dai, Ning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5400656/
https://www.ncbi.nlm.nih.gov/pubmed/28077799
http://dx.doi.org/10.18632/oncotarget.14549

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5400656/
https://www.ncbi.nlm.nih.gov/pubmed/28077799
http://dx.doi.org/10.18632/oncotarget.14549

Ejemplares similares